As the global economy mends, the 2021 growth of Antibody Drug Conjugate (ADC) Drug will have significant change from previous year. According to our (LP Information) latest study, the global Antibody Drug Conjugate (ADC) Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Antibody Drug Conjugate (ADC) Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Antibody Drug Conjugate (ADC) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibody Drug Conjugate (ADC) Drug market, reaching US$ million by the year 2028. As for the Europe Antibody Drug Conjugate (ADC) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibody Drug Conjugate (ADC) Drug players cover Oxford Bio Therapeutics, Synthon, Progenics Pharmaceuticals, and Bayer HealthCare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate (ADC) Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- by Technology
- - Mmunomedics Technology
- - Immunogen Technology
- - Seattle Genetics Technology
- - Others
- by Product Type
- - Kadcyla
- - Adcertis
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Biotechnology Companies
- Specialized Cancer Centers
- Biopharmaceutical Companies
- Academic Research Institutes
- Hospitals
- Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Oxford Bio Therapeutics
- Synthon
- Progenics Pharmaceuticals
- Bayer HealthCare
- Millennium Pharmaceuticals
- Pfizer
- Concortis Bio therapeutics
- Roche Holding AG
- Seattle Genetics
- Heidelberg Pharma
- Mersana Therapeutics
- Astellas Pharma/Agensys
- AbbVie Inc
- Celldex Therapeutics
- Immunomedics
- Agensys
- Genentech
- ImmunoGen
- Sanofi
- Genmab
- Amgen
- Novartis
- Eli Lilly
Global Antibody Drug Conjugate (ADC) Drug Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate (ADC) Drug Market Size 2017-2028
2.1.2 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antibody Drug Conjugate (ADC) Drug Segment by Type
2.2.1 Mmunomedics Technology
2.2.2 Immunogen Technology
2.2.3 Seattle Genetics Technology
2.2.4 Others
2.3 Antibody Drug Conjugate (ADC) Drug Market Size by Type
2.3.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
2.4 Antibody Drug Conjugate (ADC) Drug Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Specialized Cancer Centers
2.4.3 Biopharmaceutical Companies
2.4.4 Academic Research Institutes
2.4.5 Hospitals
2.4.6 Others
2.5 Antibody Drug Conjugate (ADC) Drug Market Size by Application
2.5.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
3 Antibody Drug Conjugate (ADC) Drug Market Size by Player
3.1 Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2020-2022)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2020-2022)
3.2 Global Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Drug Conjugate (ADC) Drug by Regions
4.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions (2017-2022)
4.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size Growth (2017-2022)
4.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size Growth (2017-2022)
4.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022)
5.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
5.3 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022)
6.2 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
6.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Drug Conjugate (ADC) Drug by Country (2017-2022)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug by Region (2017-2022)
8.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Drug Conjugate (ADC) Drug Market Forecast
10.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2023-2028)
10.1.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2023-2028)
10.1.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast
10.1.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast
10.1.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast
10.1.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast
10.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast by Country (2023-2028)
10.2.1 United States Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.2 Canada Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.3 Mexico Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.4 Brazil Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast by Region (2023-2028)
10.3.1 China Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.2 Japan Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.3 Korea Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.4 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.5 India Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.6 Australia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast by Country (2023-2028)
10.4.1 Germany Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.2 France Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.3 UK Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.4 Italy Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.5 Russia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast by Region (2023-2028)
10.5.1 Egypt Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.2 South Africa Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.3 Israel Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.4 Turkey Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.5 GCC Countries Antibody Drug Conjugate (ADC) Drug Market Forecast
10.6 Global Antibody Drug Conjugate (ADC) Drug Forecast by Type (2023-2028)
10.7 Global Antibody Drug Conjugate (ADC) Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Information
11.1.2 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Oxford Bio Therapeutics Main Business Overview
11.1.5 Oxford Bio Therapeutics Latest Developments
11.2 Synthon
11.2.1 Synthon Company Information
11.2.2 Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Synthon Main Business Overview
11.2.5 Synthon Latest Developments
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Information
11.3.2 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Progenics Pharmaceuticals Main Business Overview
11.3.5 Progenics Pharmaceuticals Latest Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Information
11.4.2 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer HealthCare Main Business Overview
11.4.5 Bayer HealthCare Latest Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Information
11.5.2 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Millennium Pharmaceuticals Main Business Overview
11.5.5 Millennium Pharmaceuticals Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Information
11.7.2 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Concortis Bio therapeutics Main Business Overview
11.7.5 Concortis Bio therapeutics Latest Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Holding AG Main Business Overview
11.8.5 Roche Holding AG Latest Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Information
11.9.2 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Seattle Genetics Main Business Overview
11.9.5 Seattle Genetics Latest Developments
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Information
11.10.2 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Heidelberg Pharma Main Business Overview
11.10.5 Heidelberg Pharma Latest Developments
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Information
11.11.2 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Mersana Therapeutics Main Business Overview
11.11.5 Mersana Therapeutics Latest Developments
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Information
11.12.2 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Astellas Pharma/Agensys Main Business Overview
11.12.5 Astellas Pharma/Agensys Latest Developments
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Information
11.13.2 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AbbVie Inc Main Business Overview
11.13.5 AbbVie Inc Latest Developments
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Information
11.14.2 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Celldex Therapeutics Main Business Overview
11.14.5 Celldex Therapeutics Latest Developments
11.15 Immunomedics
11.15.1 Immunomedics Company Information
11.15.2 Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Immunomedics Main Business Overview
11.15.5 Immunomedics Latest Developments
11.16 Agensys
11.16.1 Agensys Company Information
11.16.2 Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Agensys Main Business Overview
11.16.5 Agensys Latest Developments
11.17 Genentech
11.17.1 Genentech Company Information
11.17.2 Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Genentech Main Business Overview
11.17.5 Genentech Latest Developments
11.18 ImmunoGen
11.18.1 ImmunoGen Company Information
11.18.2 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 ImmunoGen Main Business Overview
11.18.5 ImmunoGen Latest Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Sanofi Main Business Overview
11.19.5 Sanofi Latest Developments
11.20 Genmab
11.20.1 Genmab Company Information
11.20.2 Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Genmab Main Business Overview
11.20.5 Genmab Latest Developments
11.21 Amgen
11.21.1 Amgen Company Information
11.21.2 Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Amgen Main Business Overview
11.21.5 Amgen Latest Developments
11.22 Novartis
11.22.1 Novartis Company Information
11.22.2 Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Novartis Main Business Overview
11.22.5 Novartis Latest Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Information
11.23.2 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Eli Lilly Main Business Overview
11.23.5 Eli Lilly Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Mmunomedics Technology
Table 3. Major Players of Immunogen Technology
Table 4. Major Players of Seattle Genetics Technology
Table 5. Major Players of Others
Table 6. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
Table 9. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
Table 12. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player (2020-2022)
Table 14. Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
Table 15. Antibody Drug Conjugate (ADC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2017-2022)
Table 20. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2017-2022)
Table 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
Table 24. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
Table 26. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2017-2022)
Table 28. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
Table 30. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
Table 32. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2017-2022)
Table 34. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate (ADC) Drug
Table 45. Key Market Challenges & Risks of Antibody Drug Conjugate (ADC) Drug
Table 46. Key Industry Trends of Antibody Drug Conjugate (ADC) Drug
Table 47. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Application (2023-2028)
Table 53. Oxford Bio Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 54. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 55. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Oxford Bio Therapeutics Main Business
Table 57. Oxford Bio Therapeutics Latest Developments
Table 58. Synthon Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 59. Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
Table 60. Synthon Main Business
Table 61. Synthon Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Synthon Latest Developments
Table 63. Progenics Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 64. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 65. Progenics Pharmaceuticals Main Business
Table 66. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Progenics Pharmaceuticals Latest Developments
Table 68. Bayer HealthCare Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 69. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
Table 70. Bayer HealthCare Main Business
Table 71. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Bayer HealthCare Latest Developments
Table 73. Millennium Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 74. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 75. Millennium Pharmaceuticals Main Business
Table 76. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Millennium Pharmaceuticals Latest Developments
Table 78. Pfizer Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 79. Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
Table 80. Pfizer Main Business
Table 81. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Pfizer Latest Developments
Table 83. Concortis Bio therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 84. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 85. Concortis Bio therapeutics Main Business
Table 86. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Concortis Bio therapeutics Latest Developments
Table 88. Roche Holding AG Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 89. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
Table 90. Roche Holding AG Main Business
Table 91. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Roche Holding AG Latest Developments
Table 93. Seattle Genetics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 94. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 95. Seattle Genetics Main Business
Table 96. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Seattle Genetics Latest Developments
Table 98. Heidelberg Pharma Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 99. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
Table 100. Heidelberg Pharma Main Business
Table 101. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Heidelberg Pharma Latest Developments
Table 103. Mersana Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 104. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 105. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Mersana Therapeutics Main Business
Table 107. Mersana Therapeutics Latest Developments
Table 108. Astellas Pharma/Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 109. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 110. Astellas Pharma/Agensys Main Business
Table 111. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Astellas Pharma/Agensys Latest Developments
Table 113. AbbVie Inc Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 114. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
Table 115. AbbVie Inc Main Business
Table 116. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. AbbVie Inc Latest Developments
Table 118. Celldex Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 119. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 120. Celldex Therapeutics Main Business
Table 121. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Celldex Therapeutics Latest Developments
Table 123. Immunomedics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 124. Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 125. Immunomedics Main Business
Table 126. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Immunomedics Latest Developments
Table 128. Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 129. Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 130. Agensys Main Business
Table 131. Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Agensys Latest Developments
Table 133. Genentech Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 134. Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
Table 135. Genentech Main Business
Table 136. Genentech Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Genentech Latest Developments
Table 138. ImmunoGen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 139. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 140. ImmunoGen Main Business
Table 141. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. ImmunoGen Latest Developments
Table 143. Sanofi Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 144. Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
Table 145. Sanofi Main Business
Table 146. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 147. Sanofi Latest Developments
Table 148. Genmab Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 149. Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
Table 150. Genmab Main Business
Table 151. Genmab Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 152. Genmab Latest Developments
Table 153. Amgen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 154. Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 155. Amgen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Amgen Main Business
Table 157. Amgen Latest Developments
Table 158. Novartis Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 159. Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
Table 160. Novartis Main Business
Table 161. Novartis Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Novartis Latest Developments
Table 163. Eli Lilly Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 164. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
Table 165. Eli Lilly Main Business
Table 166. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 167. Eli Lilly Latest Developments
List of Figures
Figure 1. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2021
Figure 7. Antibody Drug Conjugate (ADC) Drug in Biotechnology Companies
Figure 8. Global Antibody Drug Conjugate (ADC) Drug Market: Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. Antibody Drug Conjugate (ADC) Drug in Specialized Cancer Centers
Figure 10. Global Antibody Drug Conjugate (ADC) Drug Market: Specialized Cancer Centers (2017-2022) & ($ Millions)
Figure 11. Antibody Drug Conjugate (ADC) Drug in Biopharmaceutical Companies
Figure 12. Global Antibody Drug Conjugate (ADC) Drug Market: Biopharmaceutical Companies (2017-2022) & ($ Millions)
Figure 13. Antibody Drug Conjugate (ADC) Drug in Academic Research Institutes
Figure 14. Global Antibody Drug Conjugate (ADC) Drug Market: Academic Research Institutes (2017-2022) & ($ Millions)
Figure 15. Antibody Drug Conjugate (ADC) Drug in Hospitals
Figure 16. Global Antibody Drug Conjugate (ADC) Drug Market: Hospitals (2017-2022) & ($ Millions)
Figure 17. Antibody Drug Conjugate (ADC) Drug in Others
Figure 18. Global Antibody Drug Conjugate (ADC) Drug Market: Others (2017-2022) & ($ Millions)
Figure 19. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2021
Figure 20. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player in 2021
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2017-2022 ($ Millions)
Figure 23. APAC Antibody Drug Conjugate (ADC) Drug Market Si
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
